Detalles de la búsqueda
1.
A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors.
Ann Oncol
; 24(5): 1392-400, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23293114
2.
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours.
Eur J Cancer
; 51(16): 2275-84, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26296295
Resultados
1 -
2
de 2
1
Próxima >
>>